subscribeSubscribe
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
ACCESSWIRE
22 May 2024
Share Share
DevPro & Bespak Complete Early Feasibility Studies for New Albuterol Inhaler

DevPro & Bespak Complete Early Feasibility Studies for New Albuterol Inhaler
PHARMIWEB
08 May 2024
Share Share
Lexenpharm`s Generic Albuterol Sulfate Receives Approval In US

Lexenpharm`s Generic Albuterol Sulfate Receives Approval In US
FDA
03 May 2024
Share Share
Smart sensor cleared for use with AZ asthma, COPD inhalers

Smart sensor cleared for use with AZ asthma, COPD inhalers
Phil Taylor PHARMAPHORM
15 Apr 2024
Share Share
AIRSUPRA available as the first & only FDA-approved anti-inflammatory option

AIRSUPRA available as the first & only FDA-approved anti-inflammatory option
BUSINESSWIRE
22 Jan 2024
Share Share
Enforcement Report - Week of July 19, 2023

Enforcement Report - Week of July 19, 2023
FDA
19 Jul 2023
Share Share
Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect
FDA
07 Jul 2023
Share Share
AstraZeneca mounts dual campaigns to discuss asthma inflammation

AstraZeneca mounts dual campaigns to discuss asthma inflammation
Nick Paul Taylor FIERCE PHARMA
07 Jul 2023
Share Share
Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol Due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol Due to Container Defect
FDA
07 Jul 2023
Share Share
Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate
PR NEWSWIRE
06 Jul 2023
Share Share